Abstract 7361: Scientific rationale and successful implementation of biospecimen collection in the NCI Connect Cohort for Cancer Prevention
Nicolas Wentzensen(National Cancer Institute), Mia M. Gaudet(Cancer Prevention Institute of California), Larissa L. White, Christian C. Abnet(National Institutes of Health), Brisa Aschebrook-Kilfoy(University of Chicago), Jonine D. Figueroa, Blythe Ryerson, Mark Schmidt(Cancer Institute (WIA)), Paul S. Albert(National Cancer Institute), Stephanie J. Weinstein(National Institutes of Health), Gretchen L. Gierach(National Cancer Institute), Stacey Honda, Charles Matthews, Michelle Brotzman, Katherine Sanchez(Baylor Scott & White Health), Amanda Black(St. Elizabeth's Hospital), Kevin J. Sykes(University of Kansas Medical Center), Nicole Gerlanc(Murray State University), Jonas De Almeida, Montserrat García‐Closas(Institute of Cancer Research), Rena R. Jones(New York State Department of Health), Hannah Yang(Cancer Prevention Institute of California), Laura E. Beane Freeman(National Cancer Institute), Benjamin A. Rybicki(Henry Ford Health System), Erin Simon Schwartz, Chun‐Hung Chan(Sanford Health), Robert T. Greenlee(Marshfield Clinic), Jeanette Y. Ziegenfuss(HealthPartners), Stephen Chanock, Peter Kraft
Cited by 1
Related Papers
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
|Nature Biotechnology|2019|24.7k
Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study
|The Lancet Public Health|2020|2.3k
Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies
|JNCI Journal of the National Cancer Institute|2004|1.8k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k